160 related articles for article (PubMed ID: 18194567)
1. Enhancement of hybridoma formation, clonability and cell proliferation in a nanoparticle-doped aqueous environment.
Gavrilov-Yusim N; Hahiashvili E; Tashker M; Yavelsky V; Karnieli O; Lobel L
BMC Biotechnol; 2008 Jan; 8():3. PubMed ID: 18194567
[TBL] [Abstract][Full Text] [Related]
2. Hybridoma and CHO cell partitioning in aqueous two-phase systems.
Zijlstra GM; Michielsen MJ; de Gooijer CD; van der Pol LA; Tramper J
Biotechnol Prog; 1996; 12(3):363-70. PubMed ID: 8652121
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous cloning and selection of hybridomas and transfected cell lines in semisolid media.
Wognum B; Lee T
Methods Mol Biol; 2013; 946():133-49. PubMed ID: 23179830
[TBL] [Abstract][Full Text] [Related]
4. Non-mitogen containing conditioned medium for hybridoma production and single cell cloning.
Apiratmateekul N; Pata S; Chiampanichayakul S; Kasinrerk W
Asian Pac J Allergy Immunol; 2012 Jun; 30(2):114-22. PubMed ID: 22830290
[TBL] [Abstract][Full Text] [Related]
5. Cell growth, cell-cycle progress, and antibody production in hybridoma cells cultivated under mild hypothermic conditions.
Chong SL; Mou DG; Ali AM; Lim SH; Tey BT
Hybridoma (Larchmt); 2008 Apr; 27(2):107-11. PubMed ID: 18642675
[TBL] [Abstract][Full Text] [Related]
6. Development and manufacturability assessment of chemically-defined medium for the production of protein therapeutics in CHO cells.
Ling WL; Bai Y; Cheng C; Padawer I; Wu C
Biotechnol Prog; 2015; 31(5):1163-71. PubMed ID: 26013818
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel small molecule enhancers of protein production by cultured mammalian cells.
Allen MJ; Boyce JP; Trentalange MT; Treiber DL; Rasmussen B; Tillotson B; Davis R; Reddy P
Biotechnol Bioeng; 2008 Aug; 100(6):1193-204. PubMed ID: 18351681
[TBL] [Abstract][Full Text] [Related]
8. Culturing hybridoma cell lines for monoclonal antibody production.
Winzeler A; Wang JT
Cold Spring Harb Protoc; 2013 Jul; 2013(7):640-2. PubMed ID: 23818668
[TBL] [Abstract][Full Text] [Related]
9. A serum independent medium effective in all aspects of hybridoma technology and immunological applications.
Baker P; Knoblock K; Noll L; Wyatt D; Lydersen B
Dev Biol Stand; 1985; 60():63-72. PubMed ID: 3876250
[TBL] [Abstract][Full Text] [Related]
10. A Bioassay for Optimization of Macrophage-Conditioned Medium as a Culture Supplement to Promote Hybridoma Cell Survival and Growth.
Hnasko R; Lin AV; Stanker L; McGarvey J
Monoclon Antib Immunodiagn Immunother; 2018 Jun; 37(3):126-133. PubMed ID: 29901420
[TBL] [Abstract][Full Text] [Related]
11. The influence of the chemical composition of cell culture material on the growth and antibody production of hybridoma cells.
Heilmann K; Groth T; Behrsing O; Albrecht W; Schossig M; Lendlein A; Micheel B
J Biotechnol; 2005 Feb; 115(3):291-301. PubMed ID: 15639091
[TBL] [Abstract][Full Text] [Related]
12. Growth of hybridoma cells and antibody production in agamma calf serum.
Torres AR; Healey MC; Johnston AV; McKnight ME
Hum Antibodies Hybridomas; 1992 Oct; 3(4):206-11. PubMed ID: 1477302
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activity and monoclonal antibody production of Salmonella enteritidis O and H antigen specific hybridoma cells in static culture.
Nalbantsoy A; Bora K; Deliloglu-Gurhan I
Hybridoma (Larchmt); 2011 Apr; 30(2):189-93. PubMed ID: 21529293
[TBL] [Abstract][Full Text] [Related]
14. Influence of somatic cell hybridization and human serum on the generation and stability of human hybridomas.
Lang AB; Bruderer U
Hybridoma; 1992 Feb; 11(1):99-106. PubMed ID: 1737644
[TBL] [Abstract][Full Text] [Related]
15. Hybridoma technologies for antibody production.
Tomita M; Tsumoto K
Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody production in hollow fiber bioreactors using serum-free medium.
Heifetz AH; Braatz JA; Wolfe RA; Barry RM; Miller DA; Solomon BA
Biotechniques; 1989 Feb; 7(2):192-9. PubMed ID: 2629847
[TBL] [Abstract][Full Text] [Related]
17. Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor.
Ozturk SS; Palsson BO
Biotechnol Prog; 1991; 7(6):481-94. PubMed ID: 1367750
[TBL] [Abstract][Full Text] [Related]
18. [Defined media for hybridoma culture: do they really replace serum and why are they attractive?].
Boschetti E; Pouradier Duteil X; Sene C
Ann Pharm Fr; 1991; 49(4):198-208. PubMed ID: 1781602
[TBL] [Abstract][Full Text] [Related]
19. Methods and strategies available for the process control and optimization of monoclonal antibody production.
Fu P; Barford JP
Cytotechnology; 1994; 14(3):219-32. PubMed ID: 7765592
[TBL] [Abstract][Full Text] [Related]
20. Variations in the secretion of monoclonal antibodies by human-human hybridomas.
Gaffar SA; Surh CD; Glassy MC
Hybridoma; 1986; 5(2):93-105. PubMed ID: 3721525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
